Related Experiment Video
Updated: Jun 21, 2025

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal
Nickolas Stabellini1,2,3,4, Jennifer Cullen1,5, Marcio S Bittencourt6
1Case Western Reserve University School of Medicine, Case Western Reserve University Cleveland OH USA.
Insights
Chronic stress, measured as allostatic load (AL), increases cardiovascular risk in cancer patients. Higher AL is linked to major adverse cardiac events (MACE) in breast, lung, and colorectal cancer survivors, especially post-diagnosis.
Area of Science:
- Oncology
- Cardiology
- Stress Physiology
Background:
- Cardiovascular disease and cancer share chronic stress/allostatic load (AL) as a common risk factor.
- While AL's link to major cardiac events (MACE) is known in prostate cancer, its impact on MACE in breast, lung, and colorectal cancers was previously unstudied.
Purpose of the Study:
- To investigate the association between allostatic load (AL) and the risk of major adverse cardiac events (MACE) in patients with breast, lung, or colorectal cancer.
- To analyze how changes in AL over time influence MACE risk following cancer diagnosis.
Main Methods:
- Retrospective cohort study of 16,467 patients diagnosed with breast, lung, or colorectal cancer between 2010-2019.
- Allostatic load (AL) was modeled ordinally (0-11) and analyzed as a pre-diagnosis and time-varying exposure.
- Adjusted Fine-Gray competing risks regressions and piecewise Cox regressions were used to estimate the impact of AL on 2-year MACE.
Main Results:
- A 1-point increase in AL before diagnosis was associated with a 10% increased MACE risk in breast cancer (aHR 1.10), 16% in lung cancer (aHR 1.16), and 13% in colorectal cancer (aHR 1.13).
- The highest MACE risk was observed with a 1-point AL increase between 6 and 12 months post-diagnosis for all three cancer types.
- Major adverse cardiac events (MACE) included heart failure, ischemic stroke, acute coronary syndrome, and atrial fibrillation.
Conclusions:
- Allostatic load (AL) is a significant predictor of cardiovascular risk in patients with breast, lung, and colorectal cancer.
- AL may serve as a valuable biomarker for identifying cancer patients at high risk for MACE.
- Targeting AL could lead to timely cardiovascular interventions in cancer survivors.
Background:
Cardiovascular disease and cancer share a common risk factor: chronic stress/allostatic load (AL). A 1-point increase in AL is linked to up to a 30% higher risk of major cardiac events (MACE) in patients with prostate cancer. However, AL's role in MACE in breast cancer, lung cancer, or colorectal cancer remains unknown.
Methods And Results:
Patients ≥18 years of age diagnosed with the mentioned 3 cancers of interest (2010-2019) and followed up at a large, hybrid academic-community practice were included in this retrospective cohort study. AL was modeled as an ordinal measure (0-11). Adjusted Fine-Gray competing risks regressions estimated the impact of AL precancer diagnosis on 2-year MACE (a composite of heart failure, ischemic stroke, acute coronary syndrome, and atrial fibrillation). The effect of AL changes over time on MACE was calculated via piecewise Cox regression (before, and 2 months, 6 months, and 1 year after cancer diagnosis). Among 16 467 patients, 50.5% had breast cancer, 27.9% had lung cancer, and 21.4% had colorectal cancer. A 1-point elevation in AL before breast cancer diagnosis corresponded to a 10% heightened associated risk of MACE (adjusted hazard ratio, 1.10 [95% CI, 1.06-1.13]). Similar findings were noted in lung cancer (adjusted hazard ratio, 1.16 [95% CI, 1.12-1.20]) and colorectal cancer (adjusted hazard ratio, 1.13 [95% CI, 1.08-1.19]). When considering AL as a time-varying exposure, the peak associated MACE risk occurred with a 1-point AL rise between 6 and 12 months post- breast cancer, lung cancer, and colorectal cancer diagnosis.
Conclusions:
AL warrants investigation as a potential marker in these patients to identify those at elevated cardiovascular risk and intervene accordingly.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
05:49Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle
Published on: April 27, 2021
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Psychoneuroimmunology: Diabetes and Cancer
Introduction to Stress and Lifestyle
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: